Final FTC/DOJ Guidelines Fail to Acknowledge the Benefits of Mergers
PORTLAND, Ore. (Dec. 18, 2023) — Final updated merger-enforcement guidelines published today by the Federal Trade Commission (FTC) and U.S. Justice Department (DOJ) fail to . . .
Final FTC/DOJ Guidelines Fail to Acknowledge the Benefits of Mergers
Category template
ICLE Statement on the FCC’s Digital Discrimination Rulemaking
PORTLAND, Ore. (Nov. 15, 2023) – The International Center for Law & Economics (ICLE) offers the following statement from ICLE Director of Innovation Policy Kristian . . .
ICLE Statement on FCC’s Net Neutrality Vote
PORTLAND, Ore. (Oct. 19, 2023) – The International Center for Law & Economics (ICLE) offers the following statement from ICLE Director of Innovation Policy Kristian Stout . . .
ICLE White Paper Finds Divestitures Should Resolve Antitrust Concerns in Kroger-Albertsons Merger
PORTLAND, Ore. (Oct. 17, 2023) – The proposed $24.6 billion merger between supermarkets Kroger Co. and Albertsons Cos. Inc. has reportedly drawn regulatory scrutiny, including from . . .
ICLE White Paper Highlights Role of Prop 103 in California’s Collapsing Insurance Market
PORTLAND, Ore. (Sept. 27, 2023) – As California leaders move to take emergency action to stabilize its rapidly collapsing market for property insurance, a new . . .
ICLE Statement on the FCC Reinstatement of Net Neutrality
PORTLAND, Ore. (Sept. 26, 2023) – The International Center for Law & Economics (ICLE) offers the following statement from ICLE Director of Innovation Policy Kristian . . .
ICLE Statement on the FTC’s Amazon Case
PORTLAND, Ore. (Sept. 26, 2023) – With the Federal Trade Commission (FTC) and 17 state attorneys general announcing today that they have filed a major . . .
ICLE Announces Junior Scholars Awards and Grants Program
PORTLAND, Ore. (Sept. 7, 2023) – The International Center for Law & Economics (ICLE) is pleased to announce its 2023 Awards and Grants Program for . . .
ICLE Statement on FTC-Amgen Settlement
PORTLAND, Ore. (Sept. 1, 2023) – In light of Amgen Inc.’s announced agreement with the Federal Trade Commission (FTC) and attorneys general from six U.S. states settling challenges . . .